48,460
edits
Difference between revisions of "Thyroid gland"
Jump to navigation
Jump to search
→IHC
(→IHC) |
(→IHC) |
||
| Line 360: | Line 360: | ||
*HBME-1 +ve (focal in 4 of 6 cases<ref name=pmid16224162>{{Cite journal | last1 = Choi | first1 = YL. | last2 = Kim | first2 = MK. | last3 = Suh | first3 = JW. | last4 = Han | first4 = J. | last5 = Kim | first5 = JH. | last6 = Yang | first6 = JH. | last7 = Nam | first7 = SJ. | title = Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas. | journal = J Korean Med Sci | volume = 20 | issue = 5 | pages = 853-9 | month = Oct | year = 2005 | doi = | PMID = 16224162 }}</ref>). | *HBME-1 +ve (focal in 4 of 6 cases<ref name=pmid16224162>{{Cite journal | last1 = Choi | first1 = YL. | last2 = Kim | first2 = MK. | last3 = Suh | first3 = JW. | last4 = Han | first4 = J. | last5 = Kim | first5 = JH. | last6 = Yang | first6 = JH. | last7 = Nam | first7 = SJ. | title = Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas. | journal = J Korean Med Sci | volume = 20 | issue = 5 | pages = 853-9 | month = Oct | year = 2005 | doi = | PMID = 16224162 }}</ref>). | ||
*HCK -ve (6 of 6 cases<ref name=pmid16224162/>). | *HCK -ve (6 of 6 cases<ref name=pmid16224162/>). | ||
*CK19 +ve (focal in 4 of 6 cases<ref name=pmid16224162/>). | |||
==Minocycline associated thyroid pigmentation== | ==Minocycline associated thyroid pigmentation== | ||